BOSTON–(BUSINESS WIRE)–On May 31, 2019, Tekla Healthcare Opportunities Fund paid a monthly
distribution of $0.1125 per share. It is currently estimated that this
distribution is derived from return of capital or other capital source.
The composition of this and subsequent distributions may vary from month
to month because it may be materially impacted by future realized gains
and losses on securities. The aggregate of the net unrealized
appreciation of portfolio securities and net realized losses on sale of
securities is $16,743,559, of which $28,004,768 represents net
unrealized appreciation of portfolio securities.
The following table sets forth the estimated amounts of the current
distribution, paid on May 31, 2019, and the cumulative distributions
paid this fiscal year-to-date from the following sources: net investment
income, net realized short-term capital gains, net realized long-term
capital gains, and return of capital or other capital source. The Fund
estimates that it has distributed more than its income and net realized
capital gains; therefore, a portion of your distribution may be a return
of capital. A return of capital may occur, for example, when some or all
of the money that you have invested in the Fund is paid back to you. A
return of capital distribution does not necessarily reflect the Fund’s
investment performance and should not be confused with ‘yield’ or
‘income’. All amounts are expressed per common share.
|Net Investment Income||$0.0000||0||%||$0.0168||2||%|
|Net Realized ST Cap Gains||$0.0000||0||%||$0.0068||1||%|
|Net Realized LT Cap Gains||$0.0000||0||%||$0.0657||7||%|
|Return of Capital or Other Capital Source||$0.1125||100||%||$0.8107||90||%|
|TOTAL (per common share):||$0.1125||100||%||$0.9000||100||%|
The table below includes information relating to the Fund’s performance
based on its NAV for certain periods.
Average annual return at NAV for the period from inception through
April 30, 20192
Annualized current distribution rate expressed as a percentage of
NAV as of April 30, 2019
Cumulative total return at NAV for the fiscal year, through April
Cumulative fiscal year-to-date distribution rate expressed as a
percentage of NAV as of April 30, 20191
You should not draw any conclusions about the Fund’s investment
performance from the amount of this distribution or from the terms of
the Fund’s managed distribution policy.
The amounts and sources of distributions reported in this press release
are only estimates and are not being provided for tax reporting
purposes. The actual amounts and sources of the amounts for tax
reporting purposes will depend upon the Fund’s investment experience
during the remainder of its fiscal year and may be subject to changes
based on tax regulations. The Fund will send you a Form 1099-DIV for the
calendar year that will tell you how to report these distributions for
federal income tax purposes.
Tekla Healthcare Opportunities Fund (NYSE: THQ) is a closed-end fund
that invests in companies in the healthcare industry.
Tekla Capital Management LLC, the Fund’s investment adviser, is a
Boston, MA based healthcare-focused investment manager with
approximately $2.9 billion of assets under management as of March 31,
2019. Tekla also serves as investment adviser to Tekla Healthcare
Investors (NYSE: HQH), Tekla Life Sciences Investors (NYSE: HQL) and
Tekla World Healthcare Fund (NYSE: THW), closed-end funds that invest in
companies in the healthcare and life sciences industries. Information
regarding the Funds and Tekla Capital Management LLC can be found at www.teklacap.com.
Please contact Destra Capital Advisors, the Fund’s marketing and
investor support services agent, at [email protected]
or call (877) 855-3434 if you have any questions regarding THQ.
1 The Fund’s current fiscal year began on October 1, 2018.
Inception date was July 29, 2014, which is the date of the initial
3 Cumulative total return at NAV is the percentage
change in the Fund’s NAV and includes all distributions and assumes the
reinvestment of those distributions for the period of September 30, 2018
through April 30, 2019.
Destra Capital Advisors